APOE and Alzheimer disease: Compound library screening analyses and subsequent structural and functional characterizations identified small-molecule–based structure correctors that induce proper apoE4 folding and prevent functions of apoE4 that are related to Alzheimer’s disease pathogenesis (28, 29).